Behind the Breakthroughs Kate Sasser: How Lab-in-the-loop Turns Patient Data Into Patient Care
Apr 30, 2025
AI Snips
Chapters
Transcript
Episode notes
Kate Sasser's Career Beginnings
- Kate Sasser's initial exposure to applied science was as a research coordinator at a clinical trial site, which sparked her passion for merging biology and medicine.
- Inspired by the approval of Herceptin in 1998, she pursued a PhD and career focused on precision medicine in drug development.
From Precision to Personalized Medicine
- Precision medicine is an important step towards personalized medicine, tailoring therapies to individual patients.
- Advances in data and AI promise to extend precision medicine into true personalized therapies within the next decade.
Tempus's Dual-Impact Platform
- Tempus leverages a platform combining genomics, AI, and large-scale patient data to advance precision medicine.
- The platform serves both clinicians and drug developers, integrating data across many tests and patient profiles for better decision-making.